4 results match your criteria: "USA. lellerby@buckinstitute.org.[Affiliation]"
Nat Commun
January 2024
Buck Institute for Research on Aging, Novato, CA, 94945, USA.
Dietary restriction (DR) delays aging, but the mechanism remains unclear. We identified polymorphisms in mtd, the fly homolog of OXR1, which influenced lifespan and mtd expression in response to DR. Knockdown in adulthood inhibited DR-mediated lifespan extension in female flies.
View Article and Find Full Text PDFNeurotherapeutics
October 2019
Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA, 94945, USA.
Neurotherapeutics
October 2019
Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA, 94945, USA.
Polyglutamine expansion disorders, which include Huntington's disease, have expanded CAG repeats that result in polyglutamine expansions in affected proteins. How this specific feature leads to distinct neuropathies in 11 different diseases is a fascinating area of investigation. Most proteins affected by polyglutamine expansions are ubiquitously expressed, yet their mechanisms of selective neurotoxicity are unknown.
View Article and Find Full Text PDFMol Neurodegener
October 2013
Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA 94945, USA.
Spinocerebellar ataxia type 7 (SCA7) is caused by a toxic polyglutamine (polyQ) expansion in the N-terminus of the protein ataxin-7. Ataxin-7 has a known function in the histone acetylase complex, Spt/Ada/Gcn5 acetylase (STAGA) chromatin-remodeling complex. We hypothesized that some histone deacetylase (HDAC) family members would impact the posttranslational modification of normal and expanded ataxin-7 and possibly modulate ataxin-7 function or neurotoxicity associated with the polyQ expansion.
View Article and Find Full Text PDF